Boothbay Fund Management’s Protara Therapeutics TARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-88,941
Closed -$470K 1587
2024
Q4
$470K Buy
88,941
+71,543
+411% +$378K 0.01% 763
2024
Q3
$31.8K Sell
17,398
-2,793
-14% -$5.11K ﹤0.01% 1338
2024
Q2
$42K Sell
20,191
-2,456
-11% -$5.11K ﹤0.01% 1253
2024
Q1
$90.8K Buy
22,647
+3,783
+20% +$15.2K ﹤0.01% 1254
2023
Q4
$35.4K Hold
18,864
﹤0.01% 1394
2023
Q3
$31.5K Hold
18,864
﹤0.01% 1446
2023
Q2
$45.1K Hold
18,864
﹤0.01% 1453
2023
Q1
$59K Hold
18,864
﹤0.01% 1758
2022
Q4
$50.6K Hold
18,864
﹤0.01% 1628
2022
Q3
$56K Sell
18,864
-6,802
-27% -$20.2K ﹤0.01% 1817
2022
Q2
$75K Sell
25,666
-1,925
-7% -$5.63K ﹤0.01% 1764
2022
Q1
$141K Hold
27,591
﹤0.01% 1629
2021
Q4
$186K Sell
27,591
-19,832
-42% -$134K ﹤0.01% 1346
2021
Q3
$328K Sell
47,423
-9,460
-17% -$65.4K 0.01% 1073
2021
Q2
$554K Sell
56,883
-1,343
-2% -$13.1K 0.02% 825
2021
Q1
$916K Hold
58,226
0.03% 519
2020
Q4
$1.41M Sell
58,226
-6,457
-10% -$156K 0.05% 305
2020
Q3
$1.09M Buy
64,683
+20,659
+47% +$348K 0.07% 337
2020
Q2
$1.29M Buy
44,024
+7,091
+19% +$208K 0.09% 251
2020
Q1
$849K Buy
+36,933
New +$849K 0.07% 292
2019
Q4
Sell
-1,440
Closed -$15K 902
2019
Q3
$15K Buy
+1,440
New +$15K ﹤0.01% 649
2019
Q1
Sell
-2,707
Closed -$246K 789
2018
Q4
$246K Buy
2,707
+51
+2% +$4.64K 0.04% 360
2018
Q3
$207K Buy
2,656
+656
+33% +$51.1K 0.02% 526
2018
Q2
$196K Buy
2,000
+1,249
+166% +$122K 0.02% 509
2018
Q1
$75K Buy
+751
New +$75K 0.01% 540